Vital Chemtech Limited

Ask AI

Key metrics

Price as of 2026-04-16

Stock price
₹65.13
Market cap
156 Cr
Stock P/E
151.9
P/B
1.56
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2026
Sales35 Cr
Operating expenses (approx.)31 Cr
EBITDA4 Cr
OPM %12.0%
Other income0.24 Cr
Interest1 Cr
Depreciation2 Cr
Profit before tax0.96 Cr
Tax %12.4%
Net profit0.84 Cr
EPS (₹)₹0.36

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025Mar 2026TTM
Sales134 Cr126 CrSign in for TTM
Operating expenses (approx.)121 Cr115 CrSign in for TTM
EBITDA13 Cr11 CrSign in for TTM
OPM %10.0%8.9%Sign in for TTM
Other income2 Cr1 CrSign in for TTM
Interest2 Cr3 CrSign in for TTM
Depreciation5 Cr6 CrSign in for TTM
Profit before tax6 Cr2 CrSign in for TTM
Tax %34.7%50.8%Sign in for TTM
Net profit4 Cr1 CrSign in for TTM
EPS (₹)₹1.69₹0.44Sign in for TTM
Dividend payout %7.8%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025Mar 2026
Equity capital24 Cr24 Cr
Reserves68 Cr75 Cr
Borrowings19 Cr
Other liabilities89 Cr100 Cr
Total liabilities182 Cr219 Cr
Fixed assets (net)84 Cr58 Cr
CWIP43 Cr
Investments20 Cr13 Cr
Other assets75 Cr90 Cr
Total assets182 Cr219 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025Mar 2026
Cash from operating activity6 Cr5 Cr
Cash from investing-30 Cr-5 Cr
Cash from financing25 Cr0.58 Cr
Net cash flow0.33 Cr0.07 Cr
Free cash flow (OCF − Capex)-40 Cr-19 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025Mar 2026
ROCE %9.1%4.4%
ROE %4.4%1.0%
Debtor days128
Inventory days46111
Days payable119
Cash conversion cycle55111
Debt / equity0.19
Current ratio1.561.20
Net debt / EBITDA-0.061.60